PDCD1 and neoplasm: During the immune checkpoint blockade, polymeric NPs armed with programmed cell death protein 1 (PD-1) antibodies induce antitumor responses by freeing PD-1-expressing T-cells and overcoming tumor-induced immunosuppression.